SEIU Reports Workers at 11 Tenet Healthcare Hospitals Across California Overwhelmingly Vote to Strike, Calling for Contract to Address Pandemic Safety

October 27, 2020

SEIU reports Workers at 11 Tenet Healthcare hospitals in California have voted overwhelmingly to go on strike to demand that the giant hospital chain bargain in good faith with employees over health, safety, and other working conditions in their facilities, as caregivers continue to risk their lives caring for patients with COVID-19.

SEIU notes the strike vote covers 4,300 workers at the 11 facilities who are members of SEIU-United Healthcare Workers West. The vote margin was 96 percent in favor of the strike.

Tenet has rejected most of the workers’ proposals on pandemic safety. Workers are asking Tenet to go beyond the minimal federal guidelines to make sure the most comprehensive protections are in place.

“We are scared to come to work knowing we are at great risk of exposure to COVID-19,” said Gisella Thomas, a respiratory therapist at Desert Regional Medical Center in Palm Springs. “We want to work with management at our hospitals to increase protections for our health, our patients’ health, our families’ health, and the health of our communities. We have put forth a pandemic safety proposal that addresses issues workers are concerned about, like staffing, PPE, and increased COVID-19 testing for employees.”

Tenet has made more than $1 billion in profits in the first three quarters of 2020 and received more than $250 million in taxpayer bailout money in California alone. Tenet’s Chief Executive Officer Ron Rittenmeyer was paid more than $24 million in 2019, and the chain’s president and chief operating officer Saum Sutaria was paid nearly $14 million.

“We are calling on Tenet to increase its investment in worker safety and staffing in the middle of the worst pandemic in over a century – to ensure the safety of healthcare workers, our patients, and our entire communities.”

The strike will occur at the following Tenet hospitals in California:

INDIO: John F. Kennedy Memorial Hospital
JOSHUA TREE: High Desert Medical Center
LAKEWOOD: Lakewood Regional Medical Center
LOS ALAMITOS: Los Alamitos Medical Center
MANTECA: Doctors Hospital of Manteca
MODESTO: Doctors Medical Center
PALM SPRINGS: Desert Regional Medical Center
SAN LUIS OBISPO: Sierra Vista Regional Medical Center
SAN RAMON: San Ramon Regional Medical Center
TEMPLETON: Twin Cities Community Hospital
TURLOCK: Emanuel Medical Center

 

SourceSEIU

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.